Welcome to the Pittsburgh Cancer Conference 2011
Jeffrey Shogan Memorial Symposium Toward Personalized Anticancer Therapy

When:

Thursday, May 5, 2011; 11 a.m. to 5:45 p.m.

Where:

Herberman Conference Center at UPMC Cancer Pavilion, UPMC Shadyside
Second floor
5150 Centre Ave.
Pittsburgh, PA 15232
Directions

Overview:

This conference will present the latest information on the implications of individualizing cancer care regimens based on a variety of molecular and genetic predictive markers in differing malignancies. Included are non-small cell lung, colon, breast, head and neck, and prostate cancer as well as melanoma and acute myeloid leukemia.

Objectives:

  • Participants will recognize how and when to use biomarkers (KRAS, CP2D6, RANKL, tyrosine kinase, VEGF, etc.) to make treatment decisions, assist in outcomes prediction, and overcome therapy resistance in a variety of solid tumors.
  • Participants will be able to utilize diagnostic tools available to define disease characteristics to implement the optimal treatment regimen specific to that individual tumor.
  • Participants will maximize the integration of research evidence into daily practice.

Speakers:

“Introduction”
Adam M. Brufsky, MD, PhD, FACP
Clinical Professor of Medicine
University of Pittsburgh School of Medicine

“Memories of Dr. Shogan”
Stanley Marks, MD
Clinical Professor of Medicine
University of Pittsburgh School of Medicine

“Personalized Therapy for Advanced Non-Small Cell Lung Cancer”
Roy S. Herbst, MD, PhD
Yale University School of Medicine
New Haven, CT

“Florence Lockhart Nimick Memorial Oncology Lecture: Pharmacogenomics in Colon Cancer”
Heinz-Josef Lenz, MD, FACP
Professor of Medicine
Professor of Preventative Medicine
Keck School of Medicine, University of South California
Los Angeles, CA

“Dawn of Effective Specific Therapy for Melanoma: Growing Options for Personalized Molecular, Immunological, and Cytotoxic Therapy”
John M. Kirkwood, MD
Professor of Medicine, Dermatology, and Translational Science
University of Pittsburgh School of Medicine

“Implications of Breast Cancer Heterogeneity”
Lisa A. Carey, MD
Professor of Medicine
University of North Carolina School of Medicine
Chapel Hill, NC

“Treatment of Acute Myeloid Leukemia in a Genomic Era: Classification and Novel Strategies ”
Martin S. Tallman, MD
Professor of Medicine
Weill Cornell Medical College
New York, NY

“Individualized Therapy for Head and Neck Cancer”
Jennifer Rubin Grandis, MD, FACS
Professor of Otolaryngology and Pharmacology
University of Pittsburgh School of Medicine

“The Changing Landscape of Prostate Cancer”
Phillip Kantoff, MD
Professor of Medicine
Harvard Medical School
Boston, MA

Continuing Education Credit:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professions are awarded 0.5 continuing education credits (CEU's), which are equal to 5.5 contact hours.

Registration:

Registrations are due by Friday, April 29, by filling out the registration form and faxing it to 412-623-3650, scanning it to tonderak@upmc.edu, or mailing it to:

Professional Education
School of Nursing Bldg., Room 530
5230 Centre Ave.
Pittsburgh, PA 15232

More Information:

For more information, please contact the course registrar at 412-623-3652.

Sponsored by:

University of Pittsburgh Cancer Institute, UPMC Cancer Centers, and University of Pittsburgh School of Medicine Center for Continuing Education in the Health Sciences